InVivo Therapeutics Holdings C's ticker is NVIV and the CUSIP is 46186M100. A total of 2 filers reported holding InVivo Therapeutics Holdings C in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $49,000 | -55.5% | 37,000 | 0.0% | 0.03% | -53.6% |
| Q1 2015 | $110,000 | +124.5% | 37,000 | 0.0% | 0.06% | +115.4% |
| Q4 2014 | $49,000 | +133.3% | 37,000 | 0.0% | 0.03% | +136.4% |
| Q3 2014 | $21,000 | -44.7% | 37,000 | 0.0% | 0.01% | -50.0% |
| Q2 2014 | $38,000 | +8.6% | 37,000 | +85.0% | 0.02% | 0.0% |
| Q1 2014 | $35,000 | – | 20,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HYMAN CHARLES D | 130,000 | $135,000 | 0.02% |
| Indiana Trust & Investment Management CO | 37,000 | $38,000 | 0.02% |